| Ken Lapto Choi, | |
|
670 33rd Ave, San Francisco, CA 94121-2718 | |
| (415) 519-6295 | |
| Not Available |
| Full Name | Ken Lapto Choi |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 670 33rd Ave, San Francisco, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003428996 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 82988 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ken Lapto Choi, 670 33rd Ave, San Francisco, CA 94121-2718 Ph: (415) 519-6295 | Ken Lapto Choi, 670 33rd Ave, San Francisco, CA 94121-2718 Ph: (415) 519-6295 |
News Archive
Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that a Services Agreement has been signed with the German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen (GRCBDS) whereby GRCBDS will provide pharmaceutical development and GMP manufacturing services for Kiadis Pharma's ongoing Phase II clinical study with ATIR™.
Air ambulance rides are literal lifesavers. But how much should they cost? In the ongoing, crowdsourced "Bill of the Month" investigation, Kaiser Health News and NPR received more than a dozen bills from people around the country on the hook for medevac helicopter rides that ranged from $28,000 to $97,000.
The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a high toll on patients.
POZEN Inc., announced today the receipt of a $20 million milestone payment from AstraZeneca for the U.S. Food and Drug Administration approval of VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets on April 30th. POZEN will transfer ownership of the Investigational New Drug application and New Drug Application for VIMOVO to AstraZeneca over the next few weeks.
Experts at City of Hope and the Translational Genomics Research Institute are using one of the world's most comprehensive genomic analysis tools to map out personalized treatment plans for metastatic kidney cancer patients.
› Verified 6 days ago
Christie Biggins, PHD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3398 Mission St, San Francisco, CA 94110 Phone: 415-824-6886 | |
Hayley Park, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Saint Francis Pl, Apt 3406, San Francisco, CA 94107 Phone: 312-758-7223 | |
Tina R Li, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1230 Powell St, San Francisco, CA 94133 Phone: 650-303-1987 Fax: 415-781-8788 | |
Miss Lara Berger, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 Pine Street, San Francisco, CA 94108 Phone: 415-362-6318 Fax: 415-362-6563 | |
Kira Ostapenko, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5614 Geary Blvd, San Francisco, CA 94121 Phone: 415-752-3737 | |
Danielle Renee Weaver, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 550 Gene Friend Way Apt 614, San Francisco, CA 94158 Phone: 717-332-3863 |